From genetics to therapy: Unraveling the complexities of Richter transformation in chronic lymphocytic leukemia.
Chronic lymphocytic leukemia
Clonal evolution
Richter's transformation
Journal
Cancer treatment reviews
ISSN: 1532-1967
Titre abrégé: Cancer Treat Rev
Pays: Netherlands
ID NLM: 7502030
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
16
05
2023
revised:
22
08
2023
accepted:
24
08
2023
pubmed:
4
9
2023
medline:
4
9
2023
entrez:
3
9
2023
Statut:
ppublish
Résumé
Richter transformation (RT) refers to the progression of chronic lymphocytic leukemia, the most prevalent leukemia among adults, into a highly aggressive lymphoproliferative disorder, primarily a diffuse large B-cell lymphoma. This is a severe complication that continues to be a therapeutic challenge and remains an unmet medical need. Over the last five years, significant advances have occurred in uncovering the biological processes leading to the RT, refining criteria for properly diagnose RT from other entities, and exploring new therapeutic options beyond the ineffective chemotherapy. This review summarizes current knowledge in RT, including recent advances in the understanding of the pathogenesis of RT, in the classification of RT, and in the development of novel therapeutic strategies for this grave complication.
Identifiants
pubmed: 37660626
pii: S0305-7372(23)00112-3
doi: 10.1016/j.ctrv.2023.102619
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
102619Informations de copyright
Copyright © 2023. Published by Elsevier Ltd.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.